Annual CFF
-$1.64 M
-$16.12 M-111.33%
31 December 2023
Summary:
Synaptogenix annual cash flow from financing activities is currently -$1.64 million, with the most recent change of -$16.12 million (-111.33%) on 31 December 2023. During the last 3 years, it has risen by +$1.84 million (+52.83%). SNPX annual CFF is now -104.42% below its all-time high of $37.13 million, reached on 31 December 2021.SNPX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$4.32 M
-$4.32 M-100.00%
30 September 2024
Summary:
Synaptogenix quarterly cash flow from financing activities is currently -$4.32 million, with the most recent change of -$4.32 million (-100.00%) on 30 September 2024. Over the past year, it has dropped by -$4.32 million (-100.00%). SNPX quarterly CFF is now -122.91% below its all-time high of $18.85 million, reached on 30 June 2021.SNPX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$4.32 M
-$4.32 M-4319600.00%
30 September 2024
Summary:
Synaptogenix TTM cash flow from financing activities is currently -$4.32 million, with the most recent change of -$4.32 million (-4319600.00%) on 30 September 2024. Over the past year, it has dropped by -$16.61 million (-135.15%). SNPX TTM CFF is now -111.63% below its all-time high of $37.13 million, reached on 31 December 2021.SNPX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SNPX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -111.3% | -100.0% | -135.2% |
| 3 y3 years | +52.8% | -742.0% | -135.5% |
| 5 y5 years | - | - | - |
SNPX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -104.4% | +52.8% | -131.0% | at low | -111.6% | at low |
| 5 y | 5 years | -104.4% | +52.8% | -122.9% | +78.4% | -111.6% | +41.3% |
| alltime | all time | -104.4% | +52.8% | -122.9% | +78.4% | -111.6% | +41.3% |
Synaptogenix Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.32 M(<-9900.0%) | -$4.32 M(>+9900.0%) |
| June 2024 | - | $0.00(-100.0%) | -$100.00(-100.0%) |
| Dec 2023 | -$1.64 M(-111.3%) | -$100.00(<-9900.0%) | -$1.64 M(-113.4%) |
| Sept 2023 | - | $0.00(-100.0%) | $12.29 M(0.0%) |
| June 2023 | - | -$1.64 M(-111.8%) | $12.29 M(-15.2%) |
| Dec 2022 | $14.48 M(-61.0%) | $13.93 M(>+9900.0%) | $14.48 M(+162.3%) |
| Sept 2022 | - | $0.00(0.0%) | $5.52 M(-10.9%) |
| June 2022 | - | $0.00(-100.0%) | $6.19 M(-75.3%) |
| Mar 2022 | - | $553.20 K(-88.9%) | $25.05 M(-32.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $37.13 M(-1167.3%) | $4.97 M(+638.4%) | $37.13 M(+205.2%) |
| Sept 2021 | - | $672.80 K(-96.4%) | $12.17 M(+5.9%) |
| June 2021 | - | $18.85 M(+49.1%) | $11.49 M(-256.2%) |
| Mar 2021 | - | $12.64 M(-163.2%) | -$7.36 M(+111.5%) |
| Dec 2020 | -$3.48 M(-928.8%) | -$20.00 M(<-9900.0%) | -$3.48 M(-121.1%) |
| Sept 2020 | - | $0.00(0.0%) | $16.52 M(0.0%) |
| June 2020 | - | $0.00(-100.0%) | $16.52 M(0.0%) |
| Mar 2020 | - | $16.52 M | $16.52 M |
| Dec 2019 | $419.80 K | - | - |
FAQ
- What is Synaptogenix annual cash flow from financing activities?
- What is the all time high annual CFF for Synaptogenix?
- What is Synaptogenix annual CFF year-on-year change?
- What is Synaptogenix quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Synaptogenix?
- What is Synaptogenix quarterly CFF year-on-year change?
- What is Synaptogenix TTM cash flow from financing activities?
- What is the all time high TTM CFF for Synaptogenix?
- What is Synaptogenix TTM CFF year-on-year change?
What is Synaptogenix annual cash flow from financing activities?
The current annual CFF of SNPX is -$1.64 M
What is the all time high annual CFF for Synaptogenix?
Synaptogenix all-time high annual cash flow from financing activities is $37.13 M
What is Synaptogenix annual CFF year-on-year change?
Over the past year, SNPX annual cash flow from financing activities has changed by -$16.12 M (-111.33%)
What is Synaptogenix quarterly cash flow from financing activities?
The current quarterly CFF of SNPX is -$4.32 M
What is the all time high quarterly CFF for Synaptogenix?
Synaptogenix all-time high quarterly cash flow from financing activities is $18.85 M
What is Synaptogenix quarterly CFF year-on-year change?
Over the past year, SNPX quarterly cash flow from financing activities has changed by -$4.32 M (-100.00%)
What is Synaptogenix TTM cash flow from financing activities?
The current TTM CFF of SNPX is -$4.32 M
What is the all time high TTM CFF for Synaptogenix?
Synaptogenix all-time high TTM cash flow from financing activities is $37.13 M
What is Synaptogenix TTM CFF year-on-year change?
Over the past year, SNPX TTM cash flow from financing activities has changed by -$16.61 M (-135.15%)